In a report released yesterday, Eve Burstein from Bernstein maintained a Buy rating on Guardant Health (GH – Research Report), with a price ...

BofA raised the firm’s price target on Guardant Health (GH) to $60 from $56 and keeps a Buy rating on the shares. Sentiment for Life Sciences ...

Fintel reports that on April 10, 2025, Mizuho initiated coverage of Guardant Health (NasdaqGS:GH) with a Outperform ...

PALO ALTO, Calif., April 10, 2025--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2025 after ...

$15,500 of GUARDANT HEALTH INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Medicare Advantage Program ...

American Century Companies Inc. reduced its stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 2.5% during the fourth quarter, according to its most recent filing with the Securities and ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it has entered into an agreement ...

Guardant Health had a negative return on equity of 19,157.20% and a negative net margin of 59.05%. The company had revenue of $201.81 million during the quarter, compared to the consensus estimate ...

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2025 after market ...

With U.S. stock markets set to open in two hours, Guardant Health Inc. (GH) was up 9.1% in pre-market trading, and Brookfield Wealth Solutions Ltd. (BNT) was up 8.4%.

Morningstar brands and products Company Portfolio ...